FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks approval of a generic f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Bladder Cancer
• Breast Cancer
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma
• Ovarian Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)

Snippet

ORIG AP for DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)